CDH2 and neoplasm: N-cadherin was more frequently observed in PDTC/ATC histotype (9 cases, 60%, not significant, p = 0.193, Table 5) and in tumours presenting a recurrence/persistence of the disease (15 cases, 60%, not significant, p = 0.182, Table 5).